If you are a shareholder in Momenta Pharmaceuticals Inc’s (NASDAQ:MNTA), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolio is ...

Momenta Pharmaceuticals Inc (MNTA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing ...

Looking back to 2 days ago, Momenta Pharmaceuticals Inc (NASD: MNTA) priced a 7,250,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into ...

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors’ money because they are ...

Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. The put contract at the $16.00 strike price has a current bid of $2.55. If an ...

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are ...

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and ...

View post: 36-year-old retailer shuts down website as all stores face closure View post: Allbirds' bizarre pivot from shoes to hyperscaler proves that AI excitement is alive and well — but as silly as ...